| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |